Crossject S.A [ALCJ] vs Spineway S.A [ALSPW] Detailed Stock Comparison

Crossject S.A

Euronext
Loading...

Spineway S.A

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Crossject S.A wins in 5 metrics, Spineway S.A wins in 10 metrics, with 0 ties. Spineway S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCrossject S.ASpineway S.ABetter
P/E Ratio (TTM)N/A12.80N/A
Price-to-Book RatioN/A0.18N/A
Debt-to-Equity Ratio-7.886.46Crossject S.A
PEG Ratio9.254.27Spineway S.A
EV/EBITDA-7.56-2.05Crossject S.A
Profit Margin (TTM)0.00%-16.10%Crossject S.A
Operating Margin (TTM)-246.47%-20.87%Spineway S.A
Return on Equity478.68%-8.42%Crossject S.A
Return on Assets (TTM)-26.91%-2.79%Spineway S.A
Free Cash Flow (TTM)$-11.48M$-3.27MSpineway S.A
1-Year Return-10.46%16.67%Spineway S.A
Price-to-Sales Ratio (TTM)25.640.38Spineway S.A
Enterprise Value$91.03M$1.86MCrossject S.A
EV/Revenue Ratio22.120.16Spineway S.A
Revenue per Share (TTM)$0$0Spineway S.A
Earnings per Share (Diluted)$-0.28$0.01Spineway S.A
Beta (Stock Volatility)0.770.67Spineway S.A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Crossject S.A vs Spineway S.A Stock Performance Analysis

Loading Price Chart...

Crossject S.A
Spineway S.A
Crossject S.A Stock Overview | Spineway S.A Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Crossject S.A5.16%14.44%40.79%20.90%114.00%-4.46%
Spineway S.A7.81%7.69%7.69%7.69%40.00%55.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Crossject S.A-10.46%-30.97%-10.83%-45.27%-81.46%-81.46%
Spineway S.A16.67%16.67%16.67%16.67%16.67%16.67%

News Based Sentiment: Crossject S.A vs Spineway S.A

Crossject S.A

News based Sentiment: POSITIVE

Crossject experienced a strong month with significant funding secured from both BARDA and the American Government, coupled with positive stock performance and progress towards their EUA application. While the cash position decreased, the influx of funding and positive market reaction outweigh this concern, indicating a positive overall trajectory for the company.

View Crossject S.A News Sentiment Analysis

Spineway S.A

News sentiment data is not available for Spineway S.A at this time.

Performance & Financial Health Analysis: Crossject S.A vs Spineway S.A

MetricALCJALSPW
Market Information
Market Cap i€113.73M€4.58M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i411,454341,223
90 Day Avg. Volume i308,047353,826
Last Close€2.14€0.14
52 Week Range€0.72 - €2.75€0.07 - €0.35
% from 52W High-22.18%-60.56%
All-Time High€13.09 (Feb 24, 2014)€0.15 (Jun 10, 2025)
% from All-Time High-83.65%-6.67%
Growth Metrics
Quarterly Revenue Growth2.27%-0.14%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.00%-0.16%
Operating Margin (TTM) i-2.46%-0.21%
Return on Equity (TTM) i4.79%-0.08%
Debt to Equity (MRQ) i-7.886.46
Cash & Liquidity
Book Value per Share (MRQ)€-0.06€0.70
Cash per Share (MRQ)€0.15€0.12
Operating Cash Flow (TTM) i€-7,958,000€580,000
Levered Free Cash Flow (TTM) i€-8,143,750€121,250
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Crossject S.A vs Spineway S.A

MetricALCJALSPW
Price Ratios
P/E Ratio (TTM) iN/A12.80
Forward P/E i9.254.27
PEG Ratio i9.254.27
Price to Sales (TTM) i25.640.38
Price to Book (MRQ) iN/A0.18
Market Capitalization
Market Capitalization i€113.73M€4.58M
Enterprise Value i€91.03M€1.86M
Enterprise Value Metrics
Enterprise to Revenue i22.120.16
Enterprise to EBITDA i-7.56-2.05
Risk & Other Metrics
Beta i0.770.67
Book Value per Share (MRQ) i€-0.06€0.70

Financial Statements Comparison: Crossject S.A vs Spineway S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ALCJALSPW
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ALCJALSPW
Cash & Equivalents i€7.04M€4.52M
Total Current Assets i€15.88M€13.89M
Total Current Liabilities i€10.19M€4.23M
Long-Term Debt i€17.75M€1.66M
Total Shareholders Equity i€-2.67M€24.24M
Retained Earnings i€-15.39M€-3.87M
Property, Plant & Equipment i€10.86M€5.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ALCJALSPW
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricALCJALSPW
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i411,454341,223
Average Daily Volume (90 Day) i308,047353,826
Shares Outstanding i46.20M28.79M
Float Shares i33.40MN/A
% Held by Insiders i0.20%0.00%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Crossject S.A vs Spineway S.A

MetricALCJALSPW
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A